Abstract
The growth characteristics of 6 human colorectal tumours have been examined during serial passage in both male and female immune-deprived mice. Exponential growth is a characteristic feature, especially on very early passages. Growth rates in 5 out of the 6 tumour lines increase during the first few transplant generations. This is accompanied by a shorter exponential growth phase and an increased slope of the growth curves. Lag phases and growth rates for individual tumours are variable within a passage. Growth rates for tumours maintained within the same host are similar, and are at least partially influenced by the host. In one tumour line examined in detail, the increased growth rate is attributable to a decreased cell-loss factor, and the difference in growth rate between human colorectal tumours and their corresponding xenografts may therefore largely be due to a difference in the contribution of this factor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Houghton, J., Taylor, D. Growth characteristics of human colorectal tumours during serial passage in immune-deprived mice. Br J Cancer 37, 213–223 (1978). https://doi.org/10.1038/bjc.1978.29
Issue date:
DOI: https://doi.org/10.1038/bjc.1978.29
This article is cited by
-
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer
BMC Cancer (2020)
-
Patient-derived tumour xenografts as models for oncology drug development
Nature Reviews Clinical Oncology (2012)
-
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models
Investigational New Drugs (1996)
-
Therapeutic efficacy of the cyclopropylpyrroloindole, carzelesin, against xenografts derived from adult and childhood solid tumors
Cancer Chemotherapy and Pharmacology (1995)
-
Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
Cancer Chemotherapy and Pharmacology (1995)